InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Frazier Life Sciences VIII, L.P.. Director active across 3 companies, notably Arcutis Biotherapeutics, Inc.. Aggregated, 5 filings have been published. Total volume traded: €701k. The latest transaction was disclosed on 11 February 2022 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations5 total
€700,790112,665 shares@ €6.2201100.0% of flow
Common Stock
SEC:0001209191-22-009821:0·
Ideal exit: 8 Nov 2022 (T+270)
1,200,000 shares
Common Stock
SEC:0001209191-21-057010·
1,200,000 shares
Common Stock
SEC:0001209191-21-057010:0·
02,108,558 shares0
Common Stock
SEC:0001209191-21-032151·
02,108,558 shares0
Common Stock
SEC:0001209191-21-032151:0·
5 of 5 declarations
About Frazier Life Sciences VIII, L.P.
Frazier Life Sciences VIII, L.P. is a director and insider at Arcutis Biotherapeutics, Inc. and ALPINE IMMUNE SCIENCES, INC.
